Submissions from 2021
26905 The effect of Polypodium leucotomos extract (Fernblock) on visible light and UV-induced photoaging, Aunna Pourang, Mohsen Dourra, Nneamaka Ezekwe, Indermeet Kohli, Iltefat Hamzavi, and Henry W. Lim
28522 The impact of the SARS-CoV-2 pandemic on phototherapy utilization, Aunna Pourang, Hailey Olds, Nneamaka Ezekwe, Henry W. Lim, and Iltefat H. Hamzavi
28206 Disseminated gonococcal infection manifesting as embolic septic vasculitis, Vignesh Ramachandran and Sasank Konda
28714 Primary cutaneous Fusarium infection in an immunocompetent host, Gabrielle Robinson, Ben J. Friedman, and Chauncey A. McHargue
27568 Maintenance of repigmentation after discontinuation of ruxolitinib cream in patients with vitiligo, David Rosmarin, Amit G. Pandya, Pearl Grimes, Mark Lebwohl, Alice B. Gottlieb, Iltefat H. Hamzavi, Kathleen Butler, Fiona Kuo, Shaoceng Wei, Beth Rumberger, and John E. Harris
27426 A young man with an impressive ulcer on the chest, Ethan Sagher and Anna Axelson
27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis, Linda F. Stein Gold, Javier Alonso-Llamazares, Zoe D. Draelos, Melinda J. Gooderham, Steven E. Kempers, Mark G. Lebwohl, Darryl P. Toth, Gil Yosipovitch, Robert C. Higham, Lynn Navale, and David R. Berk
Correlation of Itch Response to Roflumilast Cream with Disease Severity and Patient-Reported Outcomes in Patients with Chronic Plaque Psoriasis, Linda F. Stein Gold, Javier Alonso-Llamazares, Zoe D. Drealos, Melinda J. Gooderham, Steven E. Kempers, Mark G. Lebwohl, Darryl P. Toth, and Gil Yosipovitch
25750 Tapinarof cream 1% once daily for plaque psoriasis: Secondary efficacy outcomes from two pivotal phase 3 trials, Linda F. Stein Gold, Andrew Blauvelt, April Armstrong, Seemal R. Desai, Howard Sofen, Lawrence J. Green, Stephen K. Tyring, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, and Stephen C. Piscitelli
Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients with Chronic Plaque Psoriasis: Results from a 52-Week, Phase 2b Open-Label Study, Linda F. Stein Gold, Melinda J. Gooderham, Kim A. Papp, Laura K. Ferris, Mark G. Lebwohl, David N. Adam, Javier Alonso-Llamazares, and H. Chih-ho Hong
26607 Proactive management using Cal/BD foam in patients with plaque psoriasis prolongs time with a health-related quality of life improvement, compared with reactive management, Linda F. Stein Gold, Ahmad Jalili, Dominique Lons Danic, Nanna Nyholm, Henrik Thoning, and Piergiacomo Calzavara-Pinton
27611 Fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion for the treatment of plaque psoriasis in patients with 3-5% body surface area (BSA) and poor quality of life (QoL), Linda F. Stein Gold, Edward Lain, Jerry Bagel, and Abby Jacobson
Proactive Management with Twice-Weekly Topical Cal/BD Foam Prolongs Treatment Efficacy Versus Reactive Management in Patients with Plaque Psoriasis, Linda F. Stein Gold, Charles Lynde, Javier Alonso-Llamazares, Philip Laws, Paul Yamauchi, Henrik Thoning, Camilla Toxvaerd, and Michael Sticherling
Efficacy and Safety of Apremilast in Patients with Mild to Moderate Psoriasis: Results from the 16- Week, Double-Blind Phase of the ADVANCE Trial, Linda F. Stein Gold, Kim Papp, Craig Leonardi, David Pariser, Lawrence Green, Neal Bhatia, Howard Sofen, and Lorne Albrecht
Crisaborole ointment, 2%, in patients 3 months of age and older with mild-to-moderate atopic dermatitis (AD), J C. Su, L J. Spelman, L F. Eichenfield, Linda F. Stein Gold, A Cha, D Graham, L Takiya, J L. Werth, C Zang, and B Vlahos
25603 Improvement in scalp psoriasis and quality of life with apremilast in patients with moderate to severe scalp psoriasis regardless of prior systemic treatment: Results from the phase 3, randomized STYLE study, Yao Wang, Linda F. Stein Gold, Mark Lebwohl, Bruce Strober, Zuoshun Zhang, and Abby Van Voorhees
28588 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study, Matthew Zirwas, Zoe D. Draelos, Janet DuBois, Leon Kircik, Angela Moore, Linda F. Stein Gold, Robert C. Higham, Lynn Navale, Patrick Burnett, and David R. Berk
Efficacy and Safety of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis in a Randomized, Double-blind, Vehicle-controlled Phase 2 Study, Matthew Zirwas, Zoe D. Draelos, Janet Dubois, Leon Kircik, Angela Y. Moore, Linda F. Stein Gold, Robert C. Higham, and Lynn Navale
Submissions from 2020
16392 Efficacy of tapinarof cream by body region in subjects with plaque psoriasis in a phase 2b randomized controlled study, R Bissonnette, Linda F. Stein Gold, L Kircik, S K. Tyring, A Tallman, and A Armstrong
15821 Efficacy and safety of carbon dioxide laser excision in hidradenitis suppurativa: Experience from an urban academic medical center, Taylor Braunberger, P Vakharia, Shanthi Narla, C Nicholson, and Ashley Parks-Miller
LB938 Efficacy of FMX101 4% topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Integrated summary from three phase 3 studies, J Del Rosso, Linda F. Stein Gold, J Weiss, L Green, V Stakias, and I Stuart
16520 Continuing medical education on acne improves dermatologists’ knowledge and competence on patient management, S J. Dermer, J M. Maeglin, and Linda F. Stein Gold
17753 Analysis of 24-week response to ruxolitinib cream for the treatment of vitiligo based on patient demographics and clinical characteristics, Iltefat Hamzavi, J E. Harris, D Rosmarin, P E. Grimes, A Pandya, A B. Gottlieb, K A. Butler, I FI Kuo, K Sun, and M Lebwohl
17955 Comparison of SPF50+ and SPF100+ sunscreens on the induction of cutaneous pigmentation over multiple days: A real-world, single-center, randomized, double-blinded evaluation, Indermeet Kohli, C Nicholson, J D. Williams, I Seo, X Tian, E Atillasoy, Henry W. Lim, and Iltefat H. Hamzavi
The infection rate of intralesional triamcinolone and the safety of compounding in dermatology for intradermal and subcutaneous injection: A retrospective medical record review, Chelsea A. Luther, James L. Griffith, Elena Kurland, Reem Al Shabeeb, Misty Eleryan, Kelley Redbord, and David M. Ozog
15485 Evaluating the safety and efficacy of intense pulsed light with radiofrequency in US patients with hidradenitis suppurativa: A split-body study, Alexis B. Lyons, Raheel Zubair, Angela Parks-Miller, Indermeet Kohli, and Iltefat H. Hamzavi
13303 Prevalence of photodermatoses in the general dermatology clinic of four academic medical centers: A multicenter retrospective analysis of 1080 patients over a 10-year period, Tasneem F. Mohammad, R Hamel, A Chahine, G L. Vick, E Boh, M BT Alora, R Mistur, E D. Baron, K Cooper, and Henry W. Lim
15838 Autoimmune comorbidities of psoriasis in US adults and children, Shanthi Narla and J I. Silverberg
18303 Ataxia telangiectasia and melanoma: The role of dermatology in ataxia telangiectasia, S Oska, Danielle Yeager, Allison Zarbo, Ben J. Friedman, and Tor Shwayder
13882 Trifarotene 50 μg/g cream: An effective and safe treatment for moderate facial and truncal acne, J D. Rosso, J Tan, J S. Weiss, Linda F. Stein Gold, F Cook-Bolden, L Eichenfield, E Tanghetti, M Graeber, A A. Saenz, and F Ahmad
Impact of Gender and Race on Outcomes of Patients Treated for Mycosis Fungoides with Total Skin Electron Beam Therapy, Eric Schaff, David Bergman, Charlotte Burmeister, Chauncey A. McHargue, Henry W. Lim, and Farzan Siddiqui
13509 Integrated safety analysis of FMX103 1.5% topical minocycline foam for the treatment of moderate to severe papulopustular rosacea: Results from two phase 3 studies, Linda F. Stein Gold, J Q. Del Rosso, L Kircik, N Bhatia, D Hooper, and W K. Nahm
17800 Open-label extension study evaluating the long-term safety, efficacy, and tolerability of FMX103 1.5% topical minocycline foam in the treatment of moderate to severe facial papulopustular rosacea, Linda F. Stein Gold, J Q. Del Rosso, L Kircik, N Bhatia, D Hooper, W K. Nahm, and I Stuart
605 Long-term management of moderate-to-severe plaque psoriasis: Maintenance of treatment success following cessation of halobetasol propionate 0.01%/tazarotene 0.045% lotion, Linda F. Stein Gold, M G. Lebwohl, N Bhatia, T Lin, and R Pillai
15324 Long-term management of moderate to severe plaque psoriasis: Maintenance of treatment success following cessation of fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in patients with baseline body surface area of 6%-12%, Linda F. Stein Gold, J S. Weiss, L J. Green, L Kircik, T L. PharMd, and S Harris
513 Crisaborole in patients ≥3 months of age with mild-to-moderate atopic dermatitis (AD), J C. Su, L J. Spelman, L F. Eichenfield, and Linda F. Stein Gold
17754 Treatment success in mild psoriasis patients with fixed-combination calcipotriene and betamethasone dipropionate foam: Results from the PSO-FAST trial, K A. Veverka, J B. Hansen, M Yaloumis, L Kircik, and Linda F. Stein Gold
Using patient education to achieve optimal results with their topical retinoid/benzoyl peroxide therapy, Colleen Vlachos and Jessica M. Hutchings
350 Histone demethylase LSD1 is required for LC embryonic development but dispensable for LC maintenance and repopulation, Xuan Wang, Yi Yao, Y Wang, Li Zhou, and Qing-Sheng Mi
15211 Treatment of moderate to severe acne with once-daily tazarotene 0.045% lotion in males: Pooled analysis of two phase 3 studies, J S. Weiss, N Bhatia, Linda F. Stein Gold, G Martin, R Pillai, and E Guenin
15517 Eczema Area and Severity Index 90 (EASI-90) responder rates with abrocitinib and relationship with quality of life (QoL) and itch in patients with moderate to severe atopic dermatitis: Results from a randomized phase 3 clinical trial, G Yosipovitch, T Bieber, Linda F. Stein Gold, S Kwatra, S Tatulych, C Nduaka, M C. Cameron, D Williams, P Biswas, and H Valdez
360 CBFβ2 is required for LC hemostasis and repopulation but not required for its embryonic development, Qian Yu, Li Zhou, and Qing-Sheng Mi
18618 A differential diagnosis for the congenital midline mass: Striated muscle hamartoma, Allison Zarbo, Kevin M. Luk, Ben J. Friedman, and Tor Shwayder
Submissions from 2019
Impact of Race and Gender on Outcomes for Total Skin Electron Beam Therapy in Mycosis Fungoides, David Bergman, Charlotte Burmeister, Chauncey McHargue, Henry W. Lim, and Farzan Siddiqui
TGFβ/Smad2/4 Signaling Pathway Is Required for Epidermal Langerhans Cell Repopulation Under Inflammation Condition but Not for Their Homeostasis, Maturation and Migration in the Steady State, Steven Cvetkovski, L Huang, G Li, X Yu, I Udo-Inyang, Congcong Yin, Li Zhou, Z Yao, and Qing-Sheng Mi
Pediatric pigmented epithelioid melanocytoma of the scalp with NKTR3 gene rearrangement, Ben J. Friedman and Angela J. Jiang
Transcriptomic profiling of tumor infiltrating cells in cutaneous squamous cell carcinoma using single-cell rna sequencing, James Glassbrook, Hongmei Peng, Yi Yao, X Wu, Li Zhou, and Qing-Sheng Mi
Rapid and effective itch relief using calcipotriol plus betamethasone dipropionate foam in patients with psoriasis, A Jalili, M Lebwohl, Linda F. Stein Gold, S B. Andersen, K L. Jensen, and D Thaci
Efficacy evaluation of an antioxidant complex on visible light-induced biologic effects, Indermeet Kohli, Alexis B. Lyons, Raheel Zubair, A F. Nahhas, Taylor L. Braunberger, M Mokhtari, E Ruvolo, Henry W. Lim, and Iltefat H. Hamzavi
Photodynamic therapy for papulopustular rosacea, Kamaria Nelson, Alison Ehrlich, Olabola Awosika, Misty Eleryan, Reem Al Shabeeb, Francesca Baruffi, and Andrew Sparks
Patient-reported outcomes in subjects with atopic dermatitis treated with tapinarof cream: Results from a Phase IIb, randomized, parallel-group study, A S. Paller, Linda F. Stein Gold, A M. Tallman, and D Rubenstein
Ultraviolet B Light Induces Rapid Changes in Gene Expression as Detected by Non-Invasive, Adhesive Skin Biopsies, A H. Rosenthal, Alexis B. Lyons, A Wilson, N Yee, and R Moy
MC2-01 Cream Has Improved Overall Psoriasis Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension, J Selmer, B Vestbjerg, M Præstegaard, and Linda F. Stein Gold
Secondary Efficacy Outcomes from a Phase 2b, Randomized Dose-Finding Study of Tapinarof Cream for the Treatment of Plaque Psoriasis, Linda F. Stein Gold, N Bhatia, A M. Tallman, and D Rubenstein
Efficacy and safety of FMX103 (1.5% minocycline foam) in the treatment of moderate-to-severe papulopustular rosacea: Results from two Phase III randomized, multicenter, double-blind, vehicle-controlled studies, Linda F. Stein Gold, J Q. Del Rosso, N D. Bhatia, D Hooper, W Nahm, and I Stuart
Safety and efficacy of a fixed combination halobetasol and tazarotene lotion in the treatment of moderate-to-severe plaque ssoriasis: Subgroup analysis, Linda F. Stein Gold, E Lain, J Bagel, T Lin, G Martin, and R Pillai
The nurse's role in melanocyte-keratinocyte transplantation procedure, N Van Haaren
Efficacy and safety of apremilast in patients with moderateto-severe plaque psoriasis of the scalp: Results of a Phase III, multicenter, randomized, placebocontrolled, double-blind study, A Van Voorhees, Linda F. Stein Gold, M Lebwohl, B Strober, C Lynde, S Tyring, A Cauthen, H Sofen, Z Zhang, M Paris, and Y Wang
Histone demethylase LSD1 is required for the embryonic development of dendritic epidermal T cells and Langerhans cells, Y Wang, Jing Zhang, Yi Yao, Jie Wang, B Yang, Li Zhou, and Qing-Sheng Mi
The H3K27 Demethylase UTX regulates skin carcinogenesis possibly through a HOXB9 pathway, Y Yang, Christos Sarantopoulos, Hongmei Peng, Congcong Yin, Yi Yao, C Li, Li Zhou, and Qing-Sheng Mi
Histone Deacetylase 3 regulates the ontogeny and maintenance of tissue-resident macrophages, Yi Yao, Q Liu, F Geissmann, Li Zhou, and Qing-Sheng Mi
Persistent improvement at three year follow-up in a patient with localized deep morphea treated with both injected and laser-assisted topical poly-l-lactic acid, Danielle Yeager and David M. Ozog
Submissions from 2018
A quality improvement initiative to standardize the time-out and specimen collection process for skin biopsies., Albert S. Antonyan, James L. Griffith, Renee Sheinin, Miranda Uzoma, Laurie L. Kohen, and Pranita V. Rambhatla
Darier-Roussy disease., Albert S. Antonyan and Holly Kerr
A review of dihydroxyacetone., Taylor L. Braunberger, LM M. Katz, N Sadrieh, and Henry W. Lim
An in vivo model for post-inflammatory hyperpigmentation., Taylor L. Braunberger, Amanda F. Nahhas, Indermeet Kohli, Tasneem F. Mohammad, Cynthia L. Nicholson, Prescilia N. Isedeh, M Al-Jamal, Nathan T. Nartker, N Karaman-Jurukovska, M Matsui, Henry W. Lim, and Iltefat Hamzavi
Carbon dioxide laser excision in hidradenitis suppurativa: Demographics, comorbidities, healing time and complications., Taylor L. Braunberger, P Vakharia, Cynthia L. Nicholson, Angie Parks-Miller, and Iltefat Hamzavi
Long-term safety of crisaborole ointment, 2%, across racial and ethnic groups, V Callender, Andrew F. Alexis, Linda F. Stein Gold, M Lebwohl, S Desai, A Paller, H M. Tan, I Vranc, W Ports, and M Zielinski
Adapalene 0.3% / benzoyl peroxide 2.5% gel plus oral doxycycline is an effective and safe option for oral isotretinoin candidates with severe inflammatory acne (non-nodulocystic/nonconglobate), James Q. Del Rosso, Linda F. Stein Gold, Sandra M. Johnson, Maria J. Rueda, Hilary Baldwin, Edward L. Lain, Megan Landis, Marta Rendon, Emil Tanghetti, and Jonathan Weiss
Fractionated CO2 laser for treatment of linear morphea: A case series., Caitlin Farmer, J L. Griffith, Henry W. Lim, and David M. Ozog
Integrative clinic at Henry Ford Health System., J V. Gaulding, Lauren Seale, Holly Kerr, and Deepak Prabhakar
The prevalence of inflammatory bowel disease in patients with hidradenitis suppurativa, Daniel A. Gold, Iltefat Hamzavi, and Cynthia L. Nicholson
Material properties of trans-iliac bone biopsies, as assessed by nanoindentation (NI), in patients with and without atypical femur fractures (AFF) on long-term bisphosphonate (BP) therapy for low bone density: Preliminary results of a prospective nested case-controlled study, L Griffin, Sudhaker D. Rao, Elizabeth Warner, S Palnitkar, Shi-Jing Qiu, and Mahalakshi Honasoge
Assessing the role of rheumatology-dermatology clinics in facilitating diagnoses and optimizing patient care beyond psoriasis, J L. Griffith, Jesse Veenstra, C A. McHargue, Kathleen Maksimowicz-McKinnon, and Pranita V. Rambhatla
A sporadic case of ectrodactyly, ectodermal dysplasia, cleft lip/palate (EEC) syndrome in a twin with unaffected parents and siblings, Daniel P. Hertel, Danielle Yeager, and Tor Shwayder
TGF-β1 regulates epidermal LCs in a Smad-independent pathway, Linting Huang and G H. Li
Improvement in scalp and nails with apremilast in patients with moderate plaque psoriasis naive to systemic and biologic therapy: 52-week results of the UNVEIL study, J M. Jackson, Ali Alikhan, Mark Lebwohl, Linda F. Stein Gold, Eugenia Levi, and Jerry Bagel
Knowledge, habits, and risk perception associated with sun exposure in patients suffering from vitiligo., E Kechichian, B Bhavnit, J-P Castelneau, S Seite, C Taieb, J M. Merurant, and Iltefat Hamzavi
The impact of trace amounts of long wavelength UVA1 on visible light induced effects, Indermeet Kohli, Taylor L. Braunberger, Amanda F. Nahhas, Nikiforos Kollias, E Ruvolo, Henry W. Lim, and Iltefat Hamzavi
Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema, Indermeet Kohli, S Chaowattanapanit, Tasneem F. Mohammad, Cynthia L. Nicholson, Sakeena Fatima, Gordon Jacobsen, Nikiforos Kollias, Henry W. Lim, and Iltefat Hamzavi
Examining disease severity and symptom improvement with patient and physician assessments: Results from a phase IV analysis of apremilast in patients with moderate plaque psoriasis, Mark G. Lebwohl, J M. Jackson, Jerry Bagel, Eugenia Levi, James C. Weaver, Linda F. Stein Gold, Ali Alikhan, Seth Forman, Benjamin Lockshin, and Kristina C. Duffin
Quality Improvement Project: Improving intake forms to make them more readable for patients in an urban clinic setting, Jennifer B. Mancuso, Lauren M. Madigan, Holly Kerr, and Pranita V. Rambhatla
Case report: Gianotti-Crosti syndrome in an adult heart transplant patient with cytomegalovirus infection., Jennifer B. Mancuso, Elena Maxim, and Pranita V. Rambhatla
Oral Polypodium leucotomos extract and its impact on visible light–induced pigmentation., Tasneem F. Mohammad, Indermeet Kohli, C L. Nicholson, German Treyger, S Chaowattanapanit, Henry W. Lim, and Iltefat Hamzavi
Treatment of acne-induced post-inflammatory hyperpigmentation with topical bakuchiol cream., Amanda F. Nahhas, Taylor L. Braunberger, Indermeet Kohli, Tasneem F. Mohammad, Cynthia Nicholson, Nathan T. Nartker, Krishna Modi, M Matsui, Henry W. Lim, and Iltefat Hamzavi
The effect of topical sunscreen plus antioxidant against the visible light biologic effects., Cynthia L. Nicholson, Indermeet Kohli, Tasneem F. Mohammad, S Chaowattanapanit, E Makino, German Treyger, Henry W. Lim, and Iltefat Hamzavi
A single center, randomized, double-blinded, multiple-exposure evaluation of SPF 50+and SPF 100+sunscreens for prevention of erythema under actual use conditions., Cynthia L. Nicholson, Indermeet Kohli, Joshua D. Williams, InSeok Seo, Prithwiraj Maitra, Henry W. Lim, and Iltefat Hamzavi
Modified purse string closure for excisional biopsy of pigmented lesions on extremities, David M. Oberlin, Dennis Porto, Matteo C. LoPiccolo, and Laurie L. Kohen
Ablation of epidermal HDAC3 and HDAC4 protects against chemically-induced skin tumorigenesis in mice, H Peng, Jesse Veenstra, X Bi, Li Zhou, and Qing-Sheng Mi
An ecchymotic nodule on the scalp of an elderly male mimicking angiosarcoma, J Saleh and Ben J. Friedman
A case of increased collagen vii expression after fractional ablative laser treatment in recessive dystrophic epidermolysis bullosa, Samantha L. Schneider, Marla N. Jahnke, K Leiferman, Marsha Chaffins, and David M. Ozog
Disseminated pruritic papules, Samantha L. Schneider, L Seale, and Ellen N. Pritchett
Blastomycosis-like pyoderma: Report of a case and discussion, Renee Sheinin, Chelsea Luther, and Holly Kerr
Impact on quality of life and satisfaction with apremilast in patients with moderate plaque psoriasis: 52-week results of the UNVEIL study, Linda F. Stein Gold, Seth Forman, Mark Lebwohl, J M. Jackson, Joana Goncalves, Eugenia Levi, and Jerry Bagel
The antiinflammatory properties of ivermectin and brimonidine in the treatment of papulopustular rosacea, Linda F. Stein Gold, Edward L. Lain, and Alison Harvey
Concurrent administration of ivermectin 1% cream with brimonidine 0.33% gel improves efficacy and tolerability in treatment of moderate-to-severe rosacea, Linda F. Stein Gold, Kim Papp, Charles W. Lynde, Edward L. Lain, Melinda Gooderham, Sandra M. Johnson, Nabil Kerrouche, and Gregor Schäfer
Consistent efficacy and safety in four double-blind vehicle-controlled studies of ivermectin 1% cream in the treatment of moderate to severe papulopustular rosacea, Linda F. Stein Gold, J P. York, and Jean Jacovella
In vitro narrowband UVB phototherapy of murine lymphocytes preferentially depletes CD8+T cells in both young and aged mice, Jesse Veenstra, Henry W. Lim, and H Gibson
TGF-beta/Smad pathway is not required for epidermal LC development, Y Xu, G Li, T Huang, Li Zhou, and Qing-Sheng Mi
miRNAs are required for embryonic development of skin immune cells, Yi Yao, Li Zhou, and Qing-Sheng Mi
